Edition:
United States

Bruker Corp (BRKR.OQ)

BRKR.OQ on NASDAQ Stock Exchange Global Select Market

24.05USD
22 Feb 2017
Change (% chg)

$-0.59 (-2.39%)
Prev Close
$24.64
Open
$24.57
Day's High
$24.62
Day's Low
$24.02
Volume
299,107
Avg. Vol
220,648
52-wk High
$29.72
52-wk Low
$19.66

BRKR.OQ

Chart for BRKR.OQ

About

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $3,857.71
Shares Outstanding(Mil.): 160.40
Dividend: 0.04
Yield (%): 0.67

Financials

  BRKR.OQ Industry Sector
P/E (TTM): 25.24 52.89 29.35
EPS (TTM): 0.95 -- --
ROI: 12.58 7.57 12.97
ROE: 21.65 11.40 14.11

BRIEF-Bruker reports Q4 GAAP EPS $0.43

* Bruker reports fourth quarter and fiscal year 2016 financial results

Feb 13 2017

BRIEF-Albany Molecular enters alliance with Bruker Daltonics, Highres Biosolutions

* Albany Molecular Research says has entered an alliance with Bruker Daltonics and Highres Biosolutions

Feb 07 2017

BRIEF-Bruker acquires Nanoindenting Leader Hysitron

* Bruker announces acquisition of Nanoindenting Leader Hysitron

Jan 24 2017

BRIEF-Bruker reports third quarter 2016 financial results

* Bruker Corp says now expects to increase its 2016 non-gaap operating margin by 100 basis points or more year-over-year

Nov 02 2016

BRIEF-Bruker announces acquisition of Nucleic Acid Testing (NAT) assays and Syndromic Panel Technology

* Bruker announces acquisition of Nucleic Acid Testing (NAT) assays and Syndromic Panel Technology to expand its maldi biotyper platform Source text for Eikon: Further company coverage:

Nov 02 2016

BRIEF-Bruker signs deal to acquire Oncovision's preclinical pet imaging business

* Bruker signs agreement to acquire Oncovision's preclinical pet imaging business

Sep 07 2016

More From Around the Web

Earnings vs. Estimates